Literature DB >> 14600186

Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study.

Olli T Raitakari1, Markus Juonala, Mika Kähönen, Leena Taittonen, Tomi Laitinen, Noora Mäki-Torkko, Mikko J Järvisalo, Matti Uhari, Eero Jokinen, Tapani Rönnemaa, Hans K Akerblom, Jorma S A Viikari.   

Abstract

CONTEXT: Exposure to cardiovascular risk factors during childhood and adolescence may be associated with the development of atherosclerosis later in life.
OBJECTIVE: To study the relationship between cardiovascular risk factors measured in childhood and adolescence and common carotid artery intima-media thickness (IMT), a marker of preclinical atherosclerosis, measured in adulthood. DESIGN, SETTING, AND PARTICIPANTS: Population-based, prospective cohort study conducted at 5 centers in Finland among 2229 white adults aged 24 to 39 years who were examined in childhood and adolescence at ages 3 to 18 years in 1980 and reexamined 21 years later, between September 2001 and January 2002. MAIN OUTCOME MEASURES: Association between cardiovascular risk variables (levels of low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglycerides; LDL-C/HDL-C ratio; systolic and diastolic blood pressure; body mass index; smoking) measured in childhood and adulthood and common carotid artery IMT measured in adulthood.
RESULTS: In multivariable models adjusted for age and sex, IMT in adulthood was significantly associated with childhood LDL-C levels (P =.001), systolic blood pressure (P<.001), body mass index (P =.007), and smoking (P =.02), and with adult systolic blood pressure (P<.001), body mass index (P<.001), and smoking (P =.004). The number of risk factors measured in 12- to 18-year-old adolescents, including high levels (ie, extreme age- and sex-specific 80th percentile) of LDL-C, systolic blood pressure, body mass index, and cigarette smoking, were directly related to carotid IMT measured in young adults at ages 33 through 39 years (P<.001 for both men and women), and remained significant after adjustment for contemporaneous risk variables. The number of risk factors measured at ages 3 to 9 years demonstrated a weak direct relationship with carotid IMT at ages 24 to 30 years in men (P =.02) but not in women (P =.63).
CONCLUSIONS: Risk factor profile assessed in 12- to 18-year-old adolescents predicts adult common carotid artery IMT independently of contemporaneous risk factors. These findings suggest that exposure to cardiovascular risk factors early in life may induce changes in arteries that contribute to the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600186     DOI: 10.1001/jama.290.17.2277

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  409 in total

1.  Assessment of endothelial function in patients with nonalcoholic fatty liver disease.

Authors:  Yasar Colak; Ebubekir Senates; Atakan Yesil; Yusuf Yilmaz; Oguzhan Ozturk; Levent Doganay; Ender Coskunpinar; Ozlem Timirci Kahraman; Banu Mesci; Celal Ulasoglu; Ilyas Tuncer
Journal:  Endocrine       Date:  2012-06-03       Impact factor: 3.633

2.  Increased intima media thickness at many arterial sites in obese adolescents with abdominal adiposity, insulin resistance, and high LDL-cholesterol.

Authors:  M Wasniewska; M Valenzise; A Manganaro; S Bombaci; R Iudicello; T Aversa; F De Luca; F Lombardo
Journal:  J Endocrinol Invest       Date:  2011-09       Impact factor: 4.256

3.  Cohort Profile: the international childhood cardiovascular cohort (i3C) consortium.

Authors:  Terence Dwyer; Cong Sun; Costan G Magnussen; Olli T Raitakari; Nicholas J Schork; Alison Venn; Trudy L Burns; Markus Juonala; Julia Steinberger; Alan R Sinaiko; Ronald J Prineas; Patricia H Davis; Jessica G Woo; John A Morrison; Stephen R Daniels; Wei Chen; Sathanur R Srinivasan; Jorma Sa Viikari; Gerald S Berenson
Journal:  Int J Epidemiol       Date:  2012-03-20       Impact factor: 7.196

Review 4.  Cardiovascular disease risk factors: a childhood perspective.

Authors:  Pradeep A Praveen; Ambuj Roy; Dorairaj Prabhakaran
Journal:  Indian J Pediatr       Date:  2012-05-27       Impact factor: 1.967

5.  First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents.

Authors:  Constadina Panagiotopoulos; Rebecca Ronsley; Dean Elbe; Jana Davidson; Derryck H Smith
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2010-05

6.  The metabolic syndrome in healthy, multiethnic adolescents in Toronto, Ontario: the use of fasting blood glucose as a simple indicator.

Authors:  Vladimir Vuksan; Valentina Peeva; Alexander Rogovik; Uljana Beljan-Zdravkovic; Mark Stavro; Alexandra Jenkins; Andre G Dias; Sudi Devanesen; John Sievenpiper; Amir Hanna
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

7.  Relation of childhood obesity/cardiometabolic phenotypes to adult cardiometabolic profile: the Bogalusa Heart Study.

Authors:  Shengxu Li; Wei Chen; Sathanur R Srinivasan; Jihua Xu; Gerald S Berenson
Journal:  Am J Epidemiol       Date:  2012-10-01       Impact factor: 4.897

8.  Genetics of C-reactive protein and complement factor H have an epistatic effect on carotid artery compliance: the Cardiovascular Risk in Young Finns Study.

Authors:  J Jylhävä; C Eklund; T Pessi; O T Raitakari; M Juonala; M Kähönen; J S A Viikari; T Lehtimäki; M Hurme
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

9.  Management of Hypertension and High Low-Density Lipoprotein in Pediatric Type 1 Diabetes.

Authors:  Michelle L Katz; Zijing Guo; Lori M Laffel
Journal:  J Pediatr       Date:  2018-02-01       Impact factor: 4.406

10.  Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis.

Authors:  O Başar; E Akbal; S Köklü; Y Tuna; E Koçak; N Başar; D Tok; H Erbiş; M Senes
Journal:  Herz       Date:  2013-01-18       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.